Real Decreto | 824/2010

Spanish Royal Decree 824/2010 regulates pharmaceutical laboratories, manufacturers of active ingredients, and the international trade of medicinal products and investigational medicines. If you are looking to "develop a feature" in a software system to ensure compliance with this regulation, you should focus on the following core regulatory requirements: 1. Authorization & Licensing (Art. 3-10) Any feature must account for the mandatory authorization by the Spanish Agency for Medicines and Health Products (AEMPS) for any laboratory involved in manufacturing, importing, or exporting medicines. Feature Idea: A Regulatory Compliance Dashboard that tracks the status of AEMPS authorizations, renewal dates, and scope of permitted activities (e.g., specific dosage forms or sterile vs. non-sterile production). 2. Qualified Person (QP) / Technical Director (Art. 13-17) The decree mandates that every laboratory have a "Technical Director" (Qualified Person) responsible for ensuring every batch is manufactured in accordance with current legislation. Feature Idea: An E-Signature & Batch Release Module that prevents the "Release" status of a product unless the designated Technical Director has digitally signed off on the batch record. 3. Good Manufacturing Practice (GMP) (Art. 18-20) The regulation requires laboratories to follow EU-harmonized Good Manufacturing Practices. Feature Idea: Integrated Audit Trail and CAPA (Corrective and Preventive Actions) Tracking to provide a "permanent record" for AEMPS inspections. 4. Raw Material & Active Ingredient Traceability (Art. 25-28) Manufacturers of active pharmaceutical ingredients (APIs) must also be registered, and laboratories must verify the quality and origin of these substances. Feature Idea: A Vendor Management System that cross-references API suppliers against the AEMPS Register and maintains records of supplier audits. 5. Foreign Trade & Investigational Products (Art. 29-38) Specific rules apply to the import/export of medicines and the manufacturing of "Investigational Medicinal Products" (IMPs) used in clinical trials. Feature Idea: An IMP Inventory Manager that separates experimental batches from commercial stock and handles specific labeling requirements for clinical trial materials. 6. Health & Safety for Staff Article 38 (as referenced in related safety literature) requires technical directors to ensure staff receive continuous training and that safety protocols for handling hazardous drugs are implemented. Feature Idea: A Training & Competency Matrix that automatically blocks staff from accessing specific manufacturing areas or systems if their safety certifications (e.g., for handling hazardous substances) are expired.

Report: Analysis of Royal Decree 824/2010 Subject: Regulation of Nursery Units for the Repopulation of Aquaculture Species. Date of Approval: June 25, 2010. Ministry: Ministry of the Environment, and Rural and Marine Affairs (Spain). 1. Executive Summary Royal Decree 824/2010 is the primary regulatory framework in Spain governing the establishment, functioning, and monitoring of nursery units (criaderos) dedicated to the reproduction and cultivation of aquatic species for repopulation purposes. Its main objective is to ensure the health status and genetic integrity of aquatic stocks released into the wild, thereby supporting the conservation of biodiversity and the sustainability of the fishing sector. 2. Objectives and Scope The decree was enacted to address the unregulated production and release of aquatic species, which posed risks of introducing diseases and altering the genetic makeup of wild populations. Key Scope:

It applies to public and private facilities dedicated to the production, holding, and supply of eggs, larvae, fry, or juveniles of aquatic species intended for release into public hydraulic domains (rivers, lakes, wetlands, and marine waters). It distinguishes between facilities for repopulation (conservation/stocking) and facilities for aquaculture production (commercial food production), though hygiene standards often overlap.

3. Key Regulatory Pillars A. Health and Sanitary Regime This is the core of the decree. It enforces strict sanitary controls to prevent the spread of pathogens. real decreto 824/2010

Animal Health Certification: All units must be free of specific diseases listed in national and EU legislation. Zoning and Compartmentalization: The decree aligns with EU directives regarding the classification of zones (disease-free status). Transport Sanitization: Strict protocols for the disinfection of vehicles and equipment used in transport.

B. Genetic Management The decree introduces criteria to preserve local biodiversity.

Prohibition of Non-Native Species: Strictly prohibits the release of non-native species unless expressly authorized under exceptional circumstances (and with sterility guarantees). Genetic Provenance: It mandates that repopulation must prioritize the use of broodstock from the same river basin or genetic population unit as the receiving waters. This prevents "genetic pollution" where mixing different strains weakens local adaptation (e.g., mixing Atlantic salmon strains with Cantabrian strains). 3-10) Any feature must account for the mandatory

C. Administrative Authorization The decree streamlines the permitting process:

It mandates a single administrative authorization that encompasses both the activity license and the necessary health certifications. Authorizations are valid for a defined period and subject to periodic review and audits.

4. Classification of Nursery Units The regulation categorizes nursery units based on their status and purpose: Impact on the Sector Positive Impacts

Official Centers: Managed by the Administration for conservation and research (e.g., municipal fish farms). Private Commercial Nurseries: Private facilities authorized to supply stock for repopulation, subject to higher scrutiny and health guarantees.

5. Impact on the Sector Positive Impacts